US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
Vikings seek new deal with Justin Jefferson; star WR absent so far from workouts, AP source says
MINNEAPOLIS (AP) — The Minnesota Vikings have one major piece of roster management remaining on thei2024-05-22Seeds from China's space station applied in breeding experiments
BEIJING, May 4 (Xinhua) -- With the return on Tuesday of the Shenzhou-17 manned spacecraft, a new ba2024-05-22- A teenage girl was 'loaned out' by her 'lover boy' boyfriend to be sexually abused by his friends in2024-05-22
House quickly rejects motion to oust Speaker Johnson
WASHINGTON (AP) — Hardline Rep. Marjorie Taylor Greene tried and failed in sudden action Wednesday t2024-05-22Concussion replacements added for Copa America under the pink substitution pass system
LUQUE, Paraguay (AP) — Coaches at next month’s Copa America will be able to make a 6th and extra sub2024-05-22Hurricanes, Blues tussle for top spot in Super Rugby Pacific
WELLINGTON, New Zealand (AP) — The league-leading Hurricanes and second-place Blues will meet Saturd2024-05-22
atest comment